Published in
American Chemical Society, Journal of Medicinal Chemistry, 17(60), p. 7524-7538, 2017
DOI: 10.1021/acs.jmedchem.7b00930
Links
Tools
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology
Journal article published in 2017 by
Florent Beaufils,
Natasa Cmiljanovic,
Vladimir Cmiljanovic,
Thomas Bohnacker,
Anna Melone,
Romina Marone,
Eileen Jackson,
Xuxiao Zhang,
Alexander Sele 
,
Chiara Borsari ,
Jürgen Mestan,
Paul Hebeisen,
Petra Hillmann,
Bernd Giese,
Marketa Zvelebil
and other authors.
,
Chiara Borsari ,
Jürgen Mestan,
Paul Hebeisen,
Petra Hillmann,
Bernd Giese,
Marketa Zvelebil
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 